Taste Masking of Topiramate by Newer Range of Ion-Exchange Resin

DOI:

https://doi.org/10.37285/ijpsn.2010.3.3.8

Authors

  • T.N. Patel
  • R P Patel
  • B V Patel

Abstract

Topiramate, is an anti-epileptic drug used to treat partial onset seizures, or primary generalized tonic-clonic seizures in children and adults. But its bitter taste became a critical issue which strongly demanded to mask the taste. Different types of ion exchange resins like Kyron T-104, Kyron T-114, Kyron T-134, Doshion P 542 were used to form complex with Topiramate. Ion exchange resin to drug ratio, effect of pH, effect of temperature, effect of resin soaking time, effect of stirring time on complex formation were optimized. Drug-resin complex was evaluated for swelling, particle size analysis and drug release from drug-resin complex. Developed taste masked drug candidate in this research work become eligible to formulate mouth disintegrating dosage form.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Topiramate, taste masking, ion-exchange resin, Drug-resin complex, Kyron, Doshion

Downloads

Published

2010-11-30

How to Cite

1.
Patel T, Patel RP, Patel BV. Taste Masking of Topiramate by Newer Range of Ion-Exchange Resin. Scopus Indexed [Internet]. 2010 Nov. 30 [cited 2024 Sep. 16];3(3):1105-10. Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/523

Issue

Section

Research Articles

References

Anand V, Raghupathi K, Garg S. Ion-Exchange resins: carrying drug delivery forward, Drug Discovery Today. 6: 905-914 (2001).

Augello M, Dell SM, Reier GE, Stamato HJ, DiMemmo LM, U.S. Patent, 6099.865, 2000.

Fernandes CM, Veiga FJ. Effect of hydrophobic nature of triacetyl-β-cyclodextrin on the complexation with nicardipine hydrochloride: physicochemical and dissolution properties of the kneaded and spray-dried complexes. Chem Pharm Bull (Tokyo). 50: 1597-1602 (2002).

Fu Y, Yang S, Jeong SH, Kimura S, Park K. Orally fast disintegrating tablets: developments, technologies, taste-masking, and clinical studies. Critical Reviews in Therapeutic Drug Carrier Systems. 21(6): 433-475 (2004).

Goodman L., Gilman A., Goodman & Gilman’s the pharmacological basis of therapeutics 11: 305-307 (2006).

Koizumi K, Watanabe Y, Morita K, Utoguchi N. New method for preparing high porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material. International Journal of Pharmaceutics, 152: 127-131 (1997).

Mennella J, Pepino Y, Reed D. Genetic and Environmental Determinants of Bitter perception and sweet perception, Journal of Pediatrics, 115(2): 216-222 (2005).

Nanda A, Kandarapu R, Garg S. An update on oral taste masking technologies for oral pharmaceuticals. Indian Journal Pharmaceutical Science, 64: 10-17 (2002).

Rang H. and Dale M., Rang & Dale's pharmacology, 6: 271-272 (2007).

Sjovall J. Methods for evaluating the taste of pediatrics formulations in children: A comparison between the facial hedonic method and the patients’ own spontaneous verbal judgement, European Journal of Pediatrics, 8: 141-147 (1984).